Inteum Company
Links
Visible Legacy
RSS
News & Resources
Inteum Company News
Inteum Library
Subscribe
Search Results - jeffrey+zink
2
Results
Sort By:
Published Date
Updated Date
Title
ID
Descending
Ascending
2011-017 Mesoporous Silica Nanoparticle Based siRNA/Drug Delivery System
Summary UCLA inventors have developed a novel delivery platform using mesoporous silica nanoparticles (MSNP) that has the ability to deliver both nucleic acids and drugs concurrently. Using this system, clinicians would be able to deliver drugs and nucleic acids that modify the expression of a series of drug resistant genes that may neutralize the effect...
Published: 10/22/2025
|
Inventor(s):
Jeffrey Zink
Keywords(s):
Category(s):
Platforms > Drug Delivery > Nanoparticles
Nanoparticles for Specific Detection and Killing of Pathogenic Bacteria (UCLA Case No. 2017-840)
SummaryUCLA researchers in the Department of Chemistry and Biochemistry and Department of Medicine have developed novel functionalized mesoporous silica nanoparticles that can specifically identify pathogenic bacteria and deliver on-target drug treatments.BackgroundBacterial infection is a common illness that affects many Americans each year. The specific...
Published: 7/17/2025
|
Inventor(s):
Marcus Horwitz
,
Jeffrey Zink
,
Daniel Clemens
,
Bai Yu Clemens
,
Bastian Ruehle
Keywords(s):
Chemical Manufacturing & Industrial/Bulk Chemicals
,
Drug Delivery
,
Infectious Diseases
,
Nanoparticles
,
Therapeutics & Vaccines
Category(s):
Platforms > Drug Delivery
,
Therapeutics
,
Therapeutics > Infectious Diseases
,
Platforms > Drug Delivery > Nanoparticles
,
Chemical > Industrial & Bulk Chemicals